These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. ACG clinical guideline: the diagnosis and management of focal liver lesions. Marrero JA; Ahn J; Rajender Reddy K; Am J Gastroenterol; 2014 Sep; 109(9):1328-47; quiz 1348. PubMed ID: 25135008 [TBL] [Abstract][Full Text] [Related]
11. Use of second generation contrast-enhanced ultrasound in the assessment of focal liver lesions. Morin SH; Lim AK; Cobbold JF; Taylor-Robinson SD World J Gastroenterol; 2007 Dec; 13(45):5963-70. PubMed ID: 18023084 [TBL] [Abstract][Full Text] [Related]
12. [Focal liver lesions: clinical usefulness of contrast-enhanced ultrasound in the selection of surgical patients]. Bartolotta TV; Sandonato L; Taibbi A; Latteri S; Soresi M; Lombardo G; Genova C; Latteri MA Chir Ital; 2009; 61(3):295-307. PubMed ID: 19694231 [TBL] [Abstract][Full Text] [Related]
13. Focal hepatic masses in pediatric patients. Adeyiga AO; Lee EY; Eisenberg RL AJR Am J Roentgenol; 2012 Oct; 199(4):W422-40. PubMed ID: 22997391 [No Abstract] [Full Text] [Related]
15. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue]. Hohmann J; Skrok J; Puls R; Albrecht T Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698 [TBL] [Abstract][Full Text] [Related]
16. Color doppler ultrasound of liver lesions: signal enhancement after intravenous injection of the ultrasound contrast agent Levovist. Ernst H; Hahn EG; Balzer T; Schlief R; Heyder N J Clin Ultrasound; 1996 Jan; 24(1):31-5. PubMed ID: 8655665 [TBL] [Abstract][Full Text] [Related]